Open Access

Identification of swine influenza virus epitopes and analysis of multiple specificities expressed by cytotoxic T cell subsets

  • Lasse E Pedersen1Email author,
  • Solvej Ø Breum1,
  • Ulla Riber1,
  • Lars E Larsen1 and
  • Gregers Jungersen1
Virology Journal201411:163

https://doi.org/10.1186/1743-422X-11-163

Received: 17 March 2014

Accepted: 1 September 2014

Published: 6 September 2014

Abstract

Background

Major histocompatibility complex (MHC) class I peptide binding and presentation are essential for antigen-specific activation of cytotoxic T lymphocytes (CTLs) and swine MHC class I molecules, also termed swine leukocyte antigens (SLA), thus play a crucial role in the process that leads to elimination of viruses such as swine influenza virus (SwIV). This study describes the identification of SLA-presented peptide epitopes that are targets for a swine CTL response, and further analyses multiple specificities expressed by SwIV activated CTL subsets.

Findings

Four SwIV derived peptides were identified as T cell epitopes using fluorescent influenza:SLA tetramers. In addition, multiple CTL specificities were analyzed using peptide sequence substitutions in two of the four epitope candidates analyzed. Interestingly both conserved and substituted peptides were found to stain the CD4-CD8+ T cell subsets indicating multiple specificities.

Conclusions

This study describes a timely and cost-effective approach for viral epitope identification in livestock animals. Analysis of T cell subsets showed multiple specificities suggesting SLA-bound epitope recognition of different conformations.

Keywords

Swine influenza virus Major histocompatibility complex Cytotoxic T cell Viral epitope

Background

During the last two centuries influenza virus has constantly challenged animal and human health by seasonal outbreaks, most recently illustrated in the emerging 2009 pandemic H1N1 virus which, according to the World Health Organization (WHO), lead to more than 18.000 human deaths. Swine influenza virus (SwIV) is a common pathogen involved in the porcine respiratory disease complex. Beyond the veterinary implications, influenza infections in pigs also imply an important public health risk due to potential inter-species transmission of new reassortant strains of influenza viruses with pandemic capacity [14]. Human influenza virus vaccines are regularly updated with contemporary strains in contrast to commercially SwIV vaccines leading to inadequate protection against antigenic diverse viruses. In order to address new vaccine approaches which, based on common T cell epitopes, are able to provide a broader protection against a range of antigenic different viral strains, it is necessary to identify the peptide epitopes that are targets for a swine cytotoxic T cell response.

The selective binding and presentation of peptides in MHC complexes play a crucial role in the adaptive immune response to infectious diseases and vaccines [5, 6]. Such peptide:MHC (pMHC) complexes are scanned by circulating CD4-CD8+ cytotoxic T cells (CTLs) of the host immune system, occasionally leading to immune activation if the peptide is of foreign origin representing a potential danger to the host. To date pMHC tetramers have been described in work related to the analysis of mice [7], human [8, 9], bovine [10], and porcine [11] immune responses. In pigs, MHC class I molecules are termed swine leukocyte antigens (SLA) and one of the most commonly occurring SLA alleles, the SLA-1*0401 [12], has recently been mapped for its peptide binding preferences [13]. This study illustrates the use of pSLA fluorescent tetramers to identify SwIV derived epitopes. In summary, porcine fluorescent tetramers were generated with carefully selected influenza virus peptide ligands to measure immune responses against swine influenza virus after immunization of SLA class I matched pigs with inactivated virus.

Methods

A total of 20 pigs were used in this study of which 16 expressed the SLA-1*0401 class I molecule. All procedures of animal handling and experimentation were approved by the Danish Animal Experiments Inspectorate. Experimental animals received chemically (C3H4O2) inactivated swine influenza A virus of different strains given in equal volumes of Freund’s Incomplete adjuvant with 4 repeated immunizations at three-week intervals (Table 1). Initially, blood samples were collected from all pigs followed by SLA allele typing using PCR-SSP [1416]. Candidate SwIV epitopes were selected using in silico predictions for binding by the online available NetMHCpan algorithm [1719], and combined with previously mapped preferences expressed by SLA-1*0401 [13]. Chosen candidate epitopes were then tested for SLA-1*0401 binding affinity using a previously described immunosorbent assay [20]. pSLA-1*0401 based fluorescent tetramers were produced as described previously [9], and porcine CD8+ cytotoxic T cell labeling was analyzed by flow cytometry. APC- and BV421-fluorochromes were used for labeling tetramers whereas PE-conjugated mAb against porcine CD8α (clone 76-2-11, BD Pharmingen) and FITC-conjugated mAb against porcine CD4 (clone 74-12-4, BD Pharmingen) were used for additional cell surface staining.
Table 1

Influenza peptide epitopes and immunization strains

SLA tetramer peptide epitopes

Immunization strains 1-5

1

2

3

4

5

SwIV candidate epitope

Viral protein of origin

AA position* in virus

Nucleotide position* in virus

A/swine/Den mark/101310- 1/2011(H1N1pdm09)

A/swine/Denmark/101568-1/2011(H1pdmN2†)

A/swine/Denmark/19126/1993 (H1N1)

A/swine/Denmark/101490-3/2011(H1N1)

A/swine/Denmark/1037-2/2011(H1N2†)

CTELKLSDY

NP

44-52

130-156

+

+

CTELQ LSDY

CTELQ LSDY

CTELQ LSDY

GTEKLTITY

PB2

623-531

1567-1593

+

+

+

+

+

SSSFSFGGF

PB2

320-328

958-984

+

+

+

+

+

YVFVGTSRY

HA

215-223

643-669

+

+

YVS VES SKY

YVS VVS SKY

YVS VVS SKY

Comparison of influenza virus candidate epitope sequences within the different viral strains used for immunizations. (+) SwIV candidate epitope sequence is 100% conserved in the viral strain used for immunization. (*) Amino acid position relative to start codon in virus A/swine/Denmark/12687/2003, (†) reassortant swine influenza virus encoding a human-like N2 gene [21]. Amino acids in bold mark substitutions in the sequence within the immunization strain compared to the respective candidate epitopes used for tetramer analysis.

Results

Virally derived T cell epitopes in swine were identified by ex vivo analysis of candidate epitope peptides, based on in silico predictions and in vitro validation. Four influenza virus derived candidate epitope peptides (CTELKLSDY, GTEKLTITY, SSSFSFGGF, YVFVGTSRY) and one synthetically designed reference peptide (ASYGAGAGY) were selected for analysis based on a prediction to be bound by the SLA-1*0401 molecule. All selected peptides had NetMHCpan prediction rank scores of 1.00 or lower meaning that the peptide had a predicted affinity within the 1 percentile best candidates compared to a pool of 1,000.000 natural peptides (Table 2) [1719]. Following in vitro testing it was found that all four influenza virus peptides were bound with high affinity by the SLA-1*0401 MHC class I molecule, and identified as T cell epitopes by ex vivo flow cytometry analysis using influenza:SLA tetramers. Positive samples were defined by a minimum threshold of 2-fold higher staining percentage compared to the negative background control, as previously set by others [22]. Six of the 16 SLA-matched pigs were found to express activated CTL populations showing specificities against the SwIV peptides post immunization (Table 3). SwIV tetramer staining above the 2-fold threshold ranged between 0.8 and 5.3% of the total CD4-CD8αhigh cell population depending on the different epitopes and animals (Table 3, bold numbers). A specific T cell subset of 6.5% of the CD4-CD8αhigh population stained positive for the GTEKLTITY epitope as compared to the negative background control of 1.2% (Figure 1). In addition, substitutions were introduced in 50% of the epitope candidates to examine individual T cell subsets in regard to the expression of multiple T cell receptor (TCR) specificities. Interestingly both conserved and substituted epitope candidates were found to stain the CD4-CD8αhigh T cell subsets. Staining percentages of epitopes including amino acid substitutions compared to their respective immunization strain are marked by an asterix (Table 3).
Table 2

Peptide predictions and affinities

Peptide sequence

NetMHCpan prediction rank

SLA-1*0401 affinity KD(nM)

CTELKLSDY

1.00

16

GTEKLTITY

0.80

34

SSSFSFGGF

0.80

378

YVFVGTSRY

0.10

325

ASYGAGAGY

0.05

19

Peptide sequences selected for affinity analysis based on NetMHCpan prediction ranks and SLA-1*0401 amino acid requirements for binding. The lower the KD value the higher the affinity for binding. Peptides having KD values <500 nM are considered as intermediate affinity ligands whereas a KD value <100 nM represents a high affinity binding peptide ligand.

Table 3

Influenza virus tetramer staining

Animal ID/SwIV strain

Tetramer SwIV peptide

Peptide substituted from immunization strain

Frequency of tetramer (APC + BV421+) cells

(Tetramer + cells subtracted negative control)

 

ASYGAGAGY

Negative control

0.80 (0.00)

1/

CTELKLSDY

No

1.70 (0.90)

1

GTEKLTITY

No

1.90 (1.10)

SSSFSFGGF

No

1.70 (0.90)

YVFVGTSRY

No

1.60 (0.80)

 

ASYGAGAGY

Negative control

0.60 (0.00)

2/

CTELKLSDY

No

1.70 (1.10)

3

GTEKLTITY

No

1.50 (0.90)

SSSFSFGGF

No

1.40 (0.80)

YVFVGTSRY

No

1.50 (0.90)

 

ASYGAGAGY

Negative control

1.20 (0.00)

CTELKLSDY

No

6.30 (5.10)

4/

GTEKLTITY

No

6.50 (5.30)

3

SSSFSFGGF

No

3.90 (2.70)

YVFVGTSRY

No

5.80 (4.60)

 

ASYGAGAGY

Negative control

2.60 (0.00)

CTELKLSDY

Yes

5.80 (3.20*)

6/

GTEKLTITY

No

5.80 (3.20)

3

SSSFSFGGF

No

4.90 (2.30)

YVFVGTSRY

Yes

5.90 (3.30*)

 

ASYGAGAGY

Negative control

0.90 (0.00)

CTELKLSDY

Yes

3.00 (2.10*)

8/

GTEKLTITY

No

2.40 (1.50)

4

SSSFSFGGF

No

1.90 (1.00)

YVFVGTSRY

Yes

2.70 (1.80*)

 

ASYGAGAGY

Negative control

1.10 (0.00)

CTELKLSDY

Yes

2.80 (1.70*)

16/

GTEKLTITY

No

2.50 (1.40)

5

SSSFSFGGF

No

2.30 (1.20)

YVFVGTSRY

Yes

2.70 (1.60*)

Tetramer staining frequencies. Percentile numbers in bold show specific tetramer staining post background subtraction. The relative background staining has been defined for each animal by a negative control tetramer (ASYGAGAGY). Italic percentile numbers indicate non-specific staining. Percentages marked by an asterix (*) indentify positive staining by influenza peptides which are sequence substituted compared to the respective immunization strains.

Figure 1

Influenza virus tetramer staining of porcine CD4 - CD8 α high T cells. SwIV tetramer staining of CD4-CD8αhigh T cell subsets. Individual samples were stained by an epitope candidate tetramer (GTEKLTITY) and a negative control tetramer (ASYGAGAGY). Singlet lymphocytes are gated in P1 (blue). CD4-CD8αhigh cells are gated in P2 (orange), and CD4-CD8αhigh APC+BV+ tetramer double positive cells are shown in P3 (green) for animal number 4. Percentages of tetramer reactive cells within the CD4-CD8αhigh population are shown for each sample.

Discussion and conclusion

This study describes a timely and cost-effective approach for viral epitope analysis and identification in livestock animals. In addition, we hypothesized CD8+ cytotoxic T cell subsets to possess multiple specificities. Interestingly, it was found that conserved as well as substituted epitopes positively stained T cell subsets suggesting SLA-bound epitope recognition of different conformations. These findings correlate with previous studies showing that CTL subsets expressing individual TCRs are capable of recognizing ligands of various conformations presented by the same MHC [23, 24].

In conclusion, the data and approaches described have great potential for future studies using the pig as a large animal model for viral epitope identification. Furthermore, by including sequence substituted MHC ligands in the analysis it was illustrated how CD4-CD8+ T cell subsets were capable of expressing multiple T cell receptor ligand specificities. Finally, identification of T cell epitopes conserved across all types, subtypes and strains of influenza viruses, and including mutations, can be valuable knowledge in terms of future vaccine design as well as in achieving a better understanding of the immune responses elicited by vaccination and natural infection.

Declarations

Funding

The authors wish to acknowledge the Danish Council for Independent Research, Technology and Production Sciences for partly financial support of the study (274-09-0281).

Authors’ Affiliations

(1)
National Veterinary Institute, Technical University of Denmark

References

  1. Kida H, Ito T, Yasuda J, Shimizu Y, Itakura C, Shortridge KF, Kawaoka Y, Webster RG: Potential for transmission of avian influenza viruses to pigs. J Gen Virol 1994,75(Pt 9):2183-2188.PubMedView ArticleGoogle Scholar
  2. Kundin WD: Hong Kong A-2 influenza virus infection among swine during a human epidemic in Taiwan. Nature 1970, 228: 857.PubMedView ArticleGoogle Scholar
  3. Torremorell M, Allerson M, Corzo C, Diaz A, Gramer M: Transmission of Influenza A Virus in Pigs. Transbound Emerg Dis 2012.Google Scholar
  4. Trebbien R, Larsen LE, Viuff BM: Distribution of sialic acid receptors and influenza A virus of avian and swine origin in experimentally infected pigs. Virol J 2011, 8: 434. 10.1186/1743-422X-8-434PubMedPubMed CentralView ArticleGoogle Scholar
  5. Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK, Lush MJ, Povey S, Talbot CC Jr, Wright MW, Wain HM, Trowsdale J, Ziegler A, Beck S: Gene map of the extended human MHC. Nat Rev Genet 2004, 5: 889-899. 10.1038/nrg1489PubMedView ArticleGoogle Scholar
  6. Kelley J, Walter L, Trowsdale J: Comparative genomics of major histocompatibility complexes. Immunogenetics 2005, 56: 683-695. 10.1007/s00251-004-0717-7PubMedView ArticleGoogle Scholar
  7. Lemke CD, Graham JB, Lubaroff DM, Salem AK: Development of an MHC class I L(d)-restricted PSA peptide-loaded tetramer for detection of PSA-specific CD8+ T cells in the mouse. Prostate Cancer Prostatic Dis 2011, 14: 118-121. 10.1038/pcan.2010.57PubMedPubMed CentralView ArticleGoogle Scholar
  8. Altman JD, Moss PA, Goulder PJ, Barouch DH, Heyzer-Williams MG, Bell JI, McMichael AJ, Davis MM: Phenotypic analysis of antigen-specific T lymphocytes. Science 1996, 274: 94-96. 10.1126/science.274.5284.94PubMedView ArticleGoogle Scholar
  9. Leisner C, Loeth N, Lamberth K, Justesen S, Sylvester-Hvid C, Schmidt EG, Claesson M, Buus S, Stryhn A: One-pot, mix-and-read peptide-MHC tetramers. PLoS One 2008, 3: e1678. 10.1371/journal.pone.0001678PubMedPubMed CentralView ArticleGoogle Scholar
  10. Norimine J, Han S, Brown WC: Quantitation of Anaplasma marginale major surface protein (MSP)1a and MSP2 epitope-specific CD4+ T lymphocytes using bovine DRB3*1101 and DRB3*1201 tetramers. Immunogenetics 2006, 58: 726-739. 10.1007/s00251-006-0140-3PubMedView ArticleGoogle Scholar
  11. Patch JR, Pedersen LE, Toka FN, Moraes M, Grubman MJ, Nielsen M, Jungersen G, Buus S, Golde WT: Induction of foot-and-mouth disease virus-specific cytotoxic T cell killing by vaccination. Clin Vaccine Immunol 2011, 18: 280-288. 10.1128/CVI.00417-10PubMedPubMed CentralView ArticleGoogle Scholar
  12. Smith DM, Lunney JK, Martens GW, Ando A, Lee JH, Ho CS, Schook L, Renard C, Chardon P: Nomenclature for factors of the SLA class-I system, 2004. Tissue Antigens 2005, 65: 136-149. 10.1111/j.1399-0039.2005.00337.xPubMedView ArticleGoogle Scholar
  13. Pedersen LE, Harndahl M, Rasmussen M, Lamberth K, Golde WT, Lund O, Nielsen M, Buus S: Porcine major histocompatibility complex (MHC) class I molecules and analysis of their peptide-binding specificities. Immunogenetics 2011, 63: 821-834. 10.1007/s00251-011-0555-3PubMedPubMed CentralView ArticleGoogle Scholar
  14. Ho CS, Rochelle ES, Martens GW, Schook LB, Smith DM: Characterization of swine leukocyte antigen polymorphism by sequence-based and PCR-SSP methods in Meishan pigs. Immunogenetics 2006, 58: 873-882. 10.1007/s00251-006-0145-yPubMedView ArticleGoogle Scholar
  15. Ho CS, Franzo-Romain MH, Lee YJ, Lee JH, Smith DM: Sequence-based characterization of swine leucocyte antigen alleles in commercially available porcine cell lines. Int J Immunogenet 2009, 36: 231-234. 10.1111/j.1744-313X.2009.00853.xPubMedView ArticleGoogle Scholar
  16. Ho CS, Lunney JK, Franzo-Romain MH, Martens GW, Lee YJ, Lee JH, Wysocki M, Rowland RR, Smith DM: Molecular characterization of swine leucocyte antigen class I genes in outbred pig populations. Anim Genet 2009, 40: 468-478. 10.1111/j.1365-2052.2009.01860.xPubMedView ArticleGoogle Scholar
  17. Hoof I, Peters B, Sidney J, Pedersen LE, Sette A, Lund O, Buus S, Nielsen M: NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics 2009, 61: 1-13. 10.1007/s00251-008-0341-zPubMedPubMed CentralView ArticleGoogle Scholar
  18. Lundegaard C, Lund O, Nielsen M: Prediction of epitopes using neural network based methods. J Immunol Methods 2011, 374: 26-34. 10.1016/j.jim.2010.10.011PubMedPubMed CentralView ArticleGoogle Scholar
  19. Nielsen M, Lundegaard C, Blicher T, Lamberth K, Harndahl M, Justesen S, Roder G, Peters B, Sette A, Lund O, Buus S: NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence. PLoS One 2007, 2: e796. 10.1371/journal.pone.0000796PubMedPubMed CentralView ArticleGoogle Scholar
  20. Sylvester-Hvid C, Kristensen N, Blicher T, Ferre H, Lauemoller SL, Wolf XA, Lamberth K, Nissen MH, Pedersen LO, Buus S: Establishment of a quantitative ELISA capable of determining peptide - MHC class I interaction. Tissue Antigens 2002, 59: 251-258. 10.1034/j.1399-0039.2002.590402.xPubMedView ArticleGoogle Scholar
  21. Breum SO, Hjulsager CK, Trebbien R, Larsen LE: Influenza a virus with a human-like n2 gene is circulating in pigs. Genome Announc 2013., 1:Google Scholar
  22. Ferrari G, Neal W, Ottinger J, Jones AM, Edwards BH, Goepfert P, Betts MR, Koup RA, Buchbinder S, McElrath MJ, Tartaglia J, Weinhold KJ: Absence of immunodominant anti-Gag p17 (SL9) responses among Gag CTL-positive, HIV-uninfected vaccine recipients expressing the HLA-A*0201 allele. J Immunol 2004, 173: 2126-2133. 10.4049/jimmunol.173.3.2126PubMedView ArticleGoogle Scholar
  23. Baker BM, Scott DR, Blevins SJ, Hawse WF: Structural and dynamic control of T-cell receptor specificity, cross-reactivity, and binding mechanism. Immunol Rev 2012, 250: 10-31. 10.1111/j.1600-065X.2012.01165.xPubMedView ArticleGoogle Scholar
  24. Frankild S, de Boer RJ, Lund O, Nielsen M, Kesmir C: Amino acid similarity accounts for T cell cross-reactivity and for "holes" in the T cell repertoire. PLoS One 2008, 3: e1831. 10.1371/journal.pone.0001831PubMedPubMed CentralView ArticleGoogle Scholar

Copyright

© Pedersen et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement